Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide in Invasive Pituitary Tumors
NCT00601289Phase 2Withdrawn
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Dec 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of temozolomide in pituitary tumor, sponsored by UCLA Jonsson Comprehensive Cancer Center. Planned start Dec 2009; status: withdrawn.
02
Drugs
temozolomide
03
Conditions
pituitary tumor
Beyond the preview
Go deeper on NCT00601289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00601289.